Kumovis

What Kumovis does

Kumovis is a German medical-technology company founded in 2017 in Munich that developed a filament-based extrusion 3D printing platform — the Kumovis R1 — purpose-built for additive manufacturing of patient-specific medical implants and instruments using high-performance polymers including PEEK, resomers, and Radel PPSU. The system's defining technical features include an integrated ISO Class 7 clean room build chamber (compliant with DIN EN ISO 14644), delta kinematics delivering 100 µm positioning accuracy, and adaptive local temperature management capable of heating the build chamber homogenously to 250°C, with each strand and layer cooled individually to optimize mechanical properties. The platform is validated to ASTM F2026 standards for medical device production and supports medical qualification processes (IQ, OQ, PQ).

The company monetized through capital-equipment sales to hospitals and medical device manufacturers for point-of-care 3D printing, with documented use cases including cranial plates, orbital plates, facial implants, spinal cages, bone plates, suture anchors, craniomaxillofacial reconstruction, orthopaedic interbody fusion devices, and medical instruments. Distribution was quote-based, supporting customers through medical qualification and producing patient-specific implants with turnaround times as short as two days from scan to surgery. Kumovis raised approximately $6 million in total disclosed funding (seed from HTGF in 2018 and a $6M Series A in 2020 led by RENOLIT and Syensqo Ventures).

In 2024, Kumovis was acquired by 3D Systems, a publicly traded additive manufacturing company; the Kumovis R1 was rebranded as the EXT 220 MED and integrated into 3D Systems' Medical Extrusion product line within its healthcare vertical. Following the acquisition, Kumovis no longer operates as an independent commercial entity — the technology and product roadmap are now executed under 3D Systems' global direct sales organization, Application Innovation Group, and broader healthcare portfolio (craniomaxillofacial, orthopaedic, orthotics and prosthetics, and point-of-care solutions). Customer references cited include Salzburg University Hospital, where the first implantation of a 3D-printed PEEK cranial plate using the platform was performed.

Name

Kumovis

Legal name

Kumovis

Website

https://kumovis.com

Company type

Private

Founded year

2017

Operating status

Acquired

Headcount range

11–50 employees

Short description

Kumovis is a Munich-based medical-technology company that developed the Kumovis R1, a filament-based 3D printer with integrated clean room for producing patient-specific PEEK implants, now operated as 3D Systems' EXT 220 MED following acquisition.

Ownership category

akta.pro rank

Product category

Medical Additive Manufacturing Equipment

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Plastics Product Manufacturing (3261)

SIC

Printing Trades Machinery & Equipment (3555), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

3D Printers (Additive Manufacturing) (HDACAEAH)

akta.pro secondary industries

Large-Format & Industrial Production 3D Printers (High-Throughput Systems) (IMAAAAAK), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ)

Keywords

• Medical 3D printing
• Additive manufacturing
• Filament extrusion systems
• Implant manufacturing
• PEEK printing

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations

Revenue model

1. Medical 3D Printer Hardware Sales: Sale of filament-based extrusion 3D printing systems designed for medical implant and instrument manufacturing. The Kumovis R1 platform (now EXT 220 MED) is sold to hospitals and medical device manufacturers for point-of-care production of patient-specific implants.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Kumovis develops filament-based extrusion 3D printing systems for medical implant manufacturing. The company's hardware enables production of patient-specific implants from high-performance polymers such as PEEK, resomers, and Radel PPSU. Systems are designed for medical-grade manufacturing in clinical and industrial settings.

Product overview

Kumovis, now part of 3D Systems following acquisition, offers the EXT 220 MED (formerly Kumovis R1) - a specialized medical-grade 3D printer for manufacturing implants and instruments. The system uses fused layer manufacturing (FLM) technology and is the only platform with an integrated clean room and temperature controls. It prints with high-performance medical polymers including PEEK and Radel PPSU, validated to ASTM F2026 standards for applications including craniomaxillofacial implants, spinal cages, and orthopedic devices.

Differentiator

Problem solved

Functional benefit

Products and services

• EXT 220 MED (formerly Kumovis R1) Filament-based extrusion 3D printing system with integrated cleanroom environment, designed for medical-grade production of patient-specific implants from polymers such as PEEK, resomers, and Radel PPSU. Targeted at medical device manufacturers, hospitals, and clinical point-of-care settings.

Quantifiable outcome

• Manufacturing time as little as two days from scan to surgery
• +4 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• 3D SystemscoreOEM/ Whitelabel/ Licensing PartnerKumovis R1 was acquired by 3D Systems and rebranded as the EXT 220 MED. This acquisition integrated Kumovis's medical-grade 3D printing technology into 3D Systems' healthcare portfolio. The EXT 220 MED continues to serve the medical implant and device market with enhanced distribution through 3D Systems' global sales organization.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• GE Additive: General Electric's additive manufacturing division offering metal 3D printing systems (Concept Laser, Arcam) used in medical implants and orthopedic devices. Comparable as a broad incumbent serving the regulated medical 3D printing market.
• Stratasys: Global 3D printing incumbent with FDM, PolyJet, and SAF technology platforms serving medical device prototyping and point-of-care applications. Comparable as a direct competitor in medical-grade polymer 3D printing hardware for hospitals and manufacturers.
• TRUMPF: German industrial machinery leader with an additive manufacturing division producing metal and polymer 3D printers, including medical implant applications. Comparable as a broader incumbent with overlapping medical extrusion technology.
• 3D Systems: Parent company of Kumovis and a global 3D printing incumbent with a broad hardware portfolio spanning SLA, SLS, metal DMP, and extrusion. Directly comparable as the acquirer and commercial channel for the EXT 220 MED, with overlapping medical device manufacturing offerings.
• Renishaw: UK-based precision engineering company with a metal additive manufacturing division serving medical implants (e.g., cranial plates, spinal devices). Comparable as a peer in regulated medical 3D printing for patient-specific implants.

Direct peers

• EOS GmbH: German-headquartered industrial 3D printing leader specializing in polymer and metal additive manufacturing systems, including medical-grade polymer platforms like PEEK. Comparable as a direct competitor in high-performance polymer extrusion systems for medical implants.
• Materialise: Belgian 3D printing services and software company with a strong medical devices and patient-specific implant business (e.g., TRUMATCH, HeartPrint). Comparable as a peer in the medical 3D printing ecosystem serving craniomaxillofacial and orthopedic implant production.

Emerging players

• Carbon: Digital Light Synthesis 3D printing company with medical-grade resin materials (e.g., Lattice structures for implants and dental applications). Comparable as an emerging player in high-throughput polymer 3D printing for medical and dental use cases.
• Formlabs: SLA and SLS 3D printer manufacturer with growing medical and dental vertical including FDA-cleared materials and surgical planning applications. Comparable as an emerging competitor in point-of-care medical 3D printing, though focused on lower-temperature resins rather than PEEK extrusion.
• Anatomics: Australian medical device company specializing in patient-specific 3D-printed implants, including the PEEK cranial implant (Implacast) that received FDA clearance. Comparable as a niche peer competing in patient-specific PEEK implants for craniomaxillofacial reconstruction.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/kumovis

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kumovis